MIMS® creates a drainage channel to reduce IOP in Glaucoma patients, ensuring a long-lasting safe and controlled fluid flow, no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs of Glaucomatous patients’ through simplicity, low cost, fewer post-surgical complications and less hospitalization.
• A novel Glaucoma treatment
• Leaves nothing behind (stent-less) thus lowering the risk of complications
• Can be easily combined with Cataract surgery
• Medication-sparing which improves patients’ quality of life
Company’s Keywords:
5
medical devices
Gmail, Google Apps, Amazon AWS, Mobile Friendly, Cloudinary
2012
Your request has been submitted successfully.
Own or work here?